Why Moderna Stock Surged Today
Shares of Moderna (NASDAQ: MRNA) popped on Wednesday after the biotech leader announced positive clinical trial results for its experimental skin cancer vaccine, developed with healthcare giant .
By the close of trading, Moderna's stock price was up more than 15%.
Image source: Getty Images.
Source Fool.com
Moderna Inc. Stock
€46.08
0.120%
With 7 Buy predictions and 9 Sell predictions the community is currently undecided on Moderna Inc..
The target price of 21 € compared with the current price of 46.08 € for the stock indicates a negative potential of -54.43%.
